This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Fusion Antibodies Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Thomas Jaquin: Innovator in Cancer Treatment
Introduction
Thomas Jaquin is a notable inventor based in Belfast, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibody molecules.
Latest Patents
Jaquin holds a patent for "Anti-AREG/HB-EGF antibodies and treatment." This patent describes cross-specific antibody molecules that exhibit binding specificity for both AREG and HBEGF. These antibody molecules have potential applications in methods of treating cancer and diseases associated with angiogenesis.
Career Highlights
Thomas Jaquin is associated with Fusion Antibodies Limited, where he continues to advance his research in antibody development. His work focuses on creating effective treatments that can significantly impact patient outcomes in oncology.
Collaborations
Jaquin collaborates with talented individuals such as Jill Caswell and Declan Doherty, who contribute to the innovative environment at Fusion Antibodies Limited.
Conclusion
Thomas Jaquin's work in developing anti-AREG/HB-EGF antibodies represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of innovation in medical research and the potential for new therapies to improve patient care.